“The BSE derivatives market share jumped to 14% from less than 1% in the last six month, led by these product launches. Continued growth and improved monetisation will lift the share of derivatives income to 35% of revenues in FY25 as against 2% in 2Q FY24. Derivatives ramp-up is the key driver for recent earnings upgrades and stock performance,” Jefferies said.
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target